Literature DB >> 11027524

GTP cyclohydrolase I is coinduced in hepatocytes stimulated to produce nitric oxide.

D A Geller1, M Di Silvio, T R Billiar, K Hatakeyama.   

Abstract

GTP cyclohydrolase I is the rate-controlling enzyme in the production of tetrahydrobiopterin (BH(4)), an essential cofactor for nitric oxide (NO) synthase. Here we show that GTP cyclohydrolase I mRNA was present in unstimulated hepatocytes and was up-regulated 2- to 3-fold concurrently with iNOS induction induced in vivo by LPS injection and in vitro by stimulation with LPS and inflammatory cytokines tumor necrosis factor alpha, interleukin-1 beta, and interferon-gamma. Hepatocyte GTP cyclohydrolase I enzyme activity increased 2-fold in vivo after LPS. This coinduction of GTP cyclohydrolase I resulted in increased total intracellular biopterin which supported induced NO synthesis. The addition of a GTP cyclohydrolase I inhibitor to the stimulated hepatocytes decreased intracellular biopterin levels and resulted in a decrease in NO production. The results show that GTP cyclohydrolase I is up-regulated by certain acute inflammatory conditions. Further, the results indicate that biopterin is essential as a cofactor for induced NO synthase activity in hepatocytes. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027524     DOI: 10.1006/bbrc.2000.3537

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Dissociation and unfolding of inducible nitric oxide synthase oxygenase domain identifies structural role of tetrahydrobiopterin in modulating the heme environment.

Authors:  Rajib Sengupta; Rupam Sahoo; Sougata Sinha Ray; Tanmay Dutta; Anjan Dasgupta; Sanjay Ghosh
Journal:  Mol Cell Biochem       Date:  2006-01-13       Impact factor: 3.396

2.  Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity.

Authors:  Galen M Pieper; Vani Nilakantan; Nadine L N Halligan; Ashwani K Khanna; Gail Hilton; Jeannette Vásquez-Vivar
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes.

Authors:  P A Loughran; D B Stolz; Y Vodovotz; S C Watkins; R L Simmons; T R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

4.  GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP.

Authors:  Sanjiv Kumar; Xutong Sun; Shruti Sharma; Saurabh Aggarwal; Kandasamy Ravi; Jeffery R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

5.  Attenuation of biopterin synthesis prevents Escherichia coli K1 invasion of brain endothelial cells and the development of meningitis in newborn mice.

Authors:  Muthusamy V Shanmuganathan; Subramanian Krishnan; Xiaowei Fu; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2012-10-24       Impact factor: 5.226

6.  Inhibition of CDKS by roscovitine suppressed LPS-induced *NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages.

Authors:  Jianhai Du; Na Wei; Tongju Guan; Hao Xu; Jianzhong An; Kirkwood A Pritchard; Yang Shi
Journal:  Am J Physiol Cell Physiol       Date:  2009-06-24       Impact factor: 4.249

7.  Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.

Authors:  Galen M Pieper; Irina A Ionova; Brian C Cooley; Raymond Q Migrino; Ashwani K Khanna; Jennifer Whitsett; Jeannette Vásquez-Vivar
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

8.  Toll-Like Receptor 4 Promotes NO Synthesis by Upregulating GCHI Expression under Oxidative Stress Conditions in Sheep Monocytes/Macrophages.

Authors:  Shoulong Deng; Kun Yu; Baolu Zhang; Yuchang Yao; Zhixian Wang; Jinlong Zhang; Xiaosheng Zhang; Guoshi Liu; Ning Li; Yixun Liu; Zhengxing Lian
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.